MIT reports experimental nanoparticle approach to reprogram immune cells
An October 13 MIT report describes lipid nanoparticles that reprogrammed natural killer cells in mouse studies of cancer and autoimmune disease.
What the record says
MIT researchers report designing lipid nanoparticles that deliver messenger RNA to natural killer cells, enabling those immune cells to recognize selected targets. The team tested the approach in mouse models, including a humanized mouse model of T-cell lymphoma and mice with autoimmune hepatitis. MIT describes the work as a possible way to avoid removing and engineering these cells outside the body; the reported results remain preclinical.
Source details and supporting locations.
Practical next step
Read MIT’s research account and linked paper for the experimental methods and limitations.
Limits and what is not established
Mouse and laboratory findings do not establish safety or effectiveness in people. This is not an approved treatment, a clinical-trial invitation or guidance for personal medical decisions.
Sources checked October 19, 2026. Later notices may change instructions or arrangements.
Original sources
MIT News: original information